4.7 Review

Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy

期刊

出版社

MDPI
DOI: 10.3390/ijms22083910

关键词

syndromic hearing loss; retinitis pigmentosa; CRISPR; antisense oligonucleotides

资金

  1. NIH [R01DC005575, R01DC012115]

向作者/读者索取更多资源

Hearing loss is a common sensory disorder affecting approximately 466 million people worldwide, with a significant portion being genetic. Usher syndrome is a syndromic form of genetic hearing loss that is often accompanied by retinitis pigmentosa and vestibular dysfunction. Currently, cochlear implantation or hearing aids are the main treatment options for Usher-related hearing loss.
Hearing loss is the most common sensory disorder with similar to 466 million people worldwide affected, representing about 5% of the population. A substantial portion of hearing loss is genetic. Hearing loss can either be non-syndromic, if hearing loss is the only clinical manifestation, or syndromic, if the hearing loss is accompanied by a collage of other clinical manifestations. Usher syndrome is a syndromic form of genetic hearing loss that is accompanied by impaired vision associated with retinitis pigmentosa and, in many cases, vestibular dysfunction. It is the most common cause of deaf-blindness. Currently cochlear implantation or hearing aids are the only treatments for Usher-related hearing loss. However, gene therapy has shown promise in treating Usher-related retinitis pigmentosa. Here we review how the etiologies of Usher-related hearing loss make it a good candidate for gene therapy and discuss how various forms of gene therapy could be applied to Usher-related hearing loss.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据